Rezolute Inc (RZLT)

INFORMATION TECHNOLOGY: SOFTWARE
SIC: PHARMACEUTICAL PREPARATIONS

201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY, CA 94065

Rezolute is advancing targeted therapies for rare, metabolic, and life-threatening diseases. Its lead clinical asset, RZ358, is in Phase 2b development as a potential treatment for CHI, a rare pediatric endocrine disorder. Its pipeline also includes RZ402, an IND-ready orally available plasma kallikrein inhibitor, which is staged to transition into clinical development for the treatment of diabetic macular edema.

Data as of 2021-06-13 09:36:49 -0400
Market Cap102.315 Million Shares Outstanding8.352 Million Avg 30-day Volume160.467 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.49 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low21.11 / 5.86 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from RZLT instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 12 9 33.33% 6 (0.35%) 5 (0.29%) 20.0%
13F shares: 2.477 Million 2.506 Million -1.17% 837.012 Thousand 869.056 Thousand -3.69%
% Ownership 29.6571 30.0082 -1.17% 10.0214 10.405 -3.69%
New Positions: 3 8 -62.5% 1 5 -80.0%
Increased Positions 2 2
Closed Positions
Reduced Positions 3 2
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RZLT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RZLT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KREHER NERISSA

  • Director
0 2021-03-03 1

HOGENHUIS WLADIMIR

  • Director
0 2021-03-03 1

ROBERTS BRIAN KENNETH SR VP, CLINIC DEVELOPMENT

  • Officer
0 2020-10-23 2

HANDOK, INC.

  • 10% Owner
102,665,019 2020-10-12 41

FAUCHET PHILIPPE

  • Director
0 2020-09-10 1

LABRUCHERIE GIL M

  • Director
47,042 2019-11-20 0

LIM JUNGHEE

  • Director
0 2019-11-20 0

ELAM NEVAN C CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-07-31 0

MANTRIPRAGADA SANKARAM CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-07-31 0

VENDOLA KEITH A. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-07-31 0

MILLER SELINE E. VP FINANCE & CAO

  • Officer
0 2019-03-04 0

SUNG YOUNG CHUL

  • Director
1,250,000 2019-02-11 0

KIM YOUNG-JIN

  • Director
1,250,000 2019-02-11 0

XOMA CORP

  • 10% Owner
8,093,010 2018-04-23 0

WELCH DAVID F

  • Director
1,854,515 2017-03-08 0

HUH HOYOUNG CHAIRMAN, SCIENTIFIC ADV. BD.

  • Officer
  • Director
0 2016-10-31 0

FIELDS MORGAN CHIEF ACCOUNTING OFFICER

  • Officer
0 2016-10-31 0

SHERMAN BARRY MICHAEL

  • Director
0 2016-10-31 0

HOWE STEVE

  • Director
0 2014-04-30 0

DOCKERY CARL

ALPHA ADVISORS, LLC

ALPHA VENTURE CAPITAL PARTNERS, L.P.

  • 10% Owner
  • SEE REMARKSSEE REMARKS
1,152,847 2014-04-01 0

KONUS ADVISORY GROUP, INC.

  • 10% Owner
5,057,693 2014-03-26 0

CHU JUE MIN

  • 10% Owner
0 2012-09-04 0

TURNOWSKI GUY SECRETARY

  • Officer
  • Director
0 2012-09-04 0

BAR NIR PRESIDENT AND TREASURER

  • Officer
  • Director
  • 10% Owner
0 2012-09-04 0

WOLKIN ORIT

  • 10% Owner
0 2012-09-04 0

KAEYO INVESTMENTS LTD

  • 10% Owner
0 2012-09-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
REZOLUTE INC RZLT 2021-06-15 22:15:02 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 21:45:03 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 21:15:03 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 20:45:03 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 20:15:04 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 19:45:03 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 19:15:02 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 18:45:03 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 18:15:03 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 17:45:03 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 17:15:03 UTC -24.5946 24.6346 9000
REZOLUTE INC RZLT 2021-06-15 16:45:03 UTC -24.0473 24.0873 9000
REZOLUTE INC RZLT 2021-06-15 16:15:03 UTC -24.0473 24.0873 9000
REZOLUTE INC RZLT 2021-06-15 15:15:03 UTC -24.0473 24.0873 10000
REZOLUTE INC RZLT 2021-06-15 14:45:03 UTC -23.5335 23.5735 8000
REZOLUTE INC RZLT 2021-06-15 14:15:02 UTC -23.5335 23.5735 8000
REZOLUTE INC RZLT 2021-06-15 13:45:03 UTC -23.5335 23.5735 8000
REZOLUTE INC RZLT 2021-06-15 13:15:03 UTC -23.5335 23.5735 8000
REZOLUTE INC RZLT 2021-06-15 12:45:03 UTC -23.5335 23.5735 3000
REZOLUTE INC RZLT 2021-06-14 22:15:03 UTC -23.5335 23.5735 5000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments